Literature DB >> 17724158

Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity.

Mototsugu Yamada1, Takashi Watanabe, Takako Miyara, Nobuyoshi Baba, Jun Saito, Yasuo Takeuchi, Fukuichi Ohsawa.   

Abstract

Cefditoren is the active form of cefditoren pivoxil, an oral cephalosporin antibiotic used for the treatment of respiratory tract infections and otitis media caused by bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella pneumoniae, and methicillin-susceptible strains of Staphylococcus aureus. Beta-lactam antibiotics, including cefditoren, target penicillin-binding proteins (PBPs), which are membrane-associated enzymes that play essential roles in the peptidoglycan biosynthetic process. To envision the binding of cefditoren to PBPs, we determined the crystal structure of a trypsin-digested form of PBP 2X from S. pneumoniae strain R6 complexed with cefditoren. There are two PBP 2X molecules (designated molecules 1 and 2) per asymmetric unit. The structure reveals that the orientation of Trp374 in each molecule changes in a different way upon the formation of the complex, but each forms a hydrophobic pocket. The methylthiazole group of the C-3 side chain of cefditoren fits into this binding pocket, which consists of residues His394, Trp374, and Thr526 in molecule 1 and residues His394, Asp375, and Thr526 in molecule 2. The formation of the complex is also accompanied by an induced-fit conformational change of the enzyme in the pocket to which the C-7 side chain of cefditoren binds. These features likely play a role in the high level of activity of cefditoren against S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724158      PMCID: PMC2151468          DOI: 10.1128/AAC.00743-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Synthesis and oral activity of ME1207, a new orally active cephalosporin.

Authors:  K Sakagami; K Atsumi; A Tamura; T Yoshida; K Nishihata; S Fukatsu
Journal:  J Antibiot (Tokyo)       Date:  1990-08       Impact factor: 2.649

2.  Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones.

Authors:  Asunción Fenoll; María-José Giménez; Olga Robledo; Pilar Coronel; Mercedes Gimeno; Julio Casal; Lorenzo Aguilar
Journal:  Int J Antimicrob Agents       Date:  2006-12-18       Impact factor: 5.283

Review 3.  Spotlight on cefditoren pivoxil in bacterial infections.

Authors:  Keri Wellington; Monique P Curran
Journal:  Treat Respir Med       Date:  2005

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  V A Barcus; K Ghanekar; M Yeo; T J Coffey; C G Dowson
Journal:  FEMS Microbiol Lett       Date:  1995-03-01       Impact factor: 2.742

6.  X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme.

Authors:  S Pares; N Mouz; Y Pétillot; R Hakenbeck; O Dideberg
Journal:  Nat Struct Biol       Date:  1996-03

7.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics.

Authors:  C G Dowson; T J Coffey; B G Spratt
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

8.  Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan.

Authors:  Yumiko Sanbongi; Takashi Ida; Midori Ishikawa; Yumi Osaki; Hiroshi Kataoka; Takahisa Suzuki; Kumiko Kondo; Fukuichi Ohsawa; Minoru Yonezawa
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae isolated in four southern European countries (ARISE project) from adult patients: results from the cefditoren surveillance program.

Authors:  F Soriano; J J Granizo; A Fenoll; M Gracia; R Fernández-Roblas; J Esteban; I Gadea; P Coronel; M Gimeno; E Ródenas; F Santos
Journal:  J Chemother       Date:  2003-04       Impact factor: 1.714

10.  Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project.

Authors:  F Soriano; J J Granizo; P Coronel; M Gimeno; E Ródenas; M Gracia; C García; R Fernández-Roblas; J Esteban; I Gadea
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283

View more
  8 in total

1.  Recognition of the β-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2.

Authors:  Avinash Singh; Joshua Tomberg; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Crystallization and preliminary crystallographic analysis of the transpeptidase domain of penicillin-binding protein 2B from Streptococcus pneumoniae.

Authors:  Mototsugu Yamada; Takashi Watanabe; Nobuyoshi Baba; Takako Miyara; Jun Saito; Yasuo Takeuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

3.  Proteochemometric model for predicting the inhibition of penicillin-binding proteins.

Authors:  Sunanta Nabu; Chanin Nantasenamat; Wiwat Owasirikul; Ratana Lawung; Chartchalerm Isarankura-Na-Ayudhya; Maris Lapins; Jarl E S Wikberg; Virapong Prachayasittikul
Journal:  J Comput Aided Mol Des       Date:  2014-10-26       Impact factor: 3.686

4.  The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into β-lactam resistance.

Authors:  Thomas M Moon; Éverton D D'Andréa; Christopher W Lee; Alexei Soares; Jean Jakoncic; Charlene Desbonnet; Monica Garcia-Solache; Lou B Rice; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

5.  Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.

Authors:  Eric Sauvage; Astrid Zervosen; Georges Dive; Raphael Herman; Ana Amoroso; Bernard Joris; Eveline Fonzé; Rex F Pratt; André Luxen; Paulette Charlier; Frédéric Kerff
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

6.  Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae.

Authors:  Mototsugu Yamada; Takashi Watanabe; Nobuyoshi Baba; Yasuo Takeuchi; Fukuichi Ohsawa; Shuichi Gomi
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

Review 7.  Cefditoren in upper and lower community-acquired respiratory tract infections.

Authors:  Francisco Soriano; María-José Giménez; Lorenzo Aguilar
Journal:  Drug Des Devel Ther       Date:  2011-02-09       Impact factor: 4.162

8.  Bioactivity Studies of β-Lactam Derived Polycyclic Fused Pyrroli-Dine/Pyrrolizidine Derivatives in Dentistry: In Vitro, In Vivo and In Silico Studies.

Authors:  Gowri Meiyazhagan; Rajesh Raju; Sofi Beaula Winfred; Bhavani Mannivanan; Hemadev Bhoopalan; Venkatesh Shankar; Sathiya Sekar; Deepa Parvathi Venkatachalam; Ravishankar Pitani; Venkateshbabu Nagendrababu; Malini Thaiman; Kandaswamy Devivanayagam; Jeyakanthan Jayaraman; Raghunathan Ragavachary; Ganesh Venkatraman
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.